6-149661790-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004690.4(LATS1):c.3332C>T(p.Ser1111Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000487 in 1,602,948 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000052 ( 1 hom. )
Consequence
LATS1
NM_004690.4 missense
NM_004690.4 missense
Scores
1
3
15
Clinical Significance
Conservation
PhyloP100: 5.30
Genes affected
LATS1 (HGNC:6514): (large tumor suppressor kinase 1) The protein encoded by this gene is a putative serine/threonine kinase that localizes to the mitotic apparatus and complexes with cell cycle controller CDC2 kinase in early mitosis. The protein is phosphorylated in a cell-cycle dependent manner, with late prophase phosphorylation remaining through metaphase. The N-terminal region of the protein binds CDC2 to form a complex showing reduced H1 histone kinase activity, indicating a role as a negative regulator of CDC2/cyclin A. In addition, the C-terminal kinase domain binds to its own N-terminal region, suggesting potential negative regulation through interference with complex formation via intramolecular binding. Biochemical and genetic data suggest a role as a tumor suppressor. This is supported by studies in knockout mice showing development of soft-tissue sarcomas, ovarian stromal cell tumors and a high sensitivity to carcinogenic treatments. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.18264592).
BS2
High AC in GnomAdExome4 at 75 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LATS1 | NM_004690.4 | c.3332C>T | p.Ser1111Leu | missense_variant | 8/8 | ENST00000543571.6 | NP_004681.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LATS1 | ENST00000543571.6 | c.3332C>T | p.Ser1111Leu | missense_variant | 8/8 | 1 | NM_004690.4 | ENSP00000437550.1 | ||
LATS1 | ENST00000253339.9 | c.3332C>T | p.Ser1111Leu | missense_variant | 7/7 | 1 | ENSP00000253339.5 | |||
LATS1 | ENST00000441107.5 | n.*3019C>T | non_coding_transcript_exon_variant | 9/9 | 1 | ENSP00000403815.1 | ||||
LATS1 | ENST00000441107.5 | n.*3019C>T | 3_prime_UTR_variant | 9/9 | 1 | ENSP00000403815.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151244Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151244
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000368 AC: 9AN: 244484Hom.: 0 AF XY: 0.0000378 AC XY: 5AN XY: 132158
GnomAD3 exomes
AF:
AC:
9
AN:
244484
Hom.:
AF XY:
AC XY:
5
AN XY:
132158
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000517 AC: 75AN: 1451586Hom.: 1 Cov.: 31 AF XY: 0.0000596 AC XY: 43AN XY: 721324
GnomAD4 exome
AF:
AC:
75
AN:
1451586
Hom.:
Cov.:
31
AF XY:
AC XY:
43
AN XY:
721324
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151362Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73848
GnomAD4 genome
AF:
AC:
3
AN:
151362
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
73848
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 01, 2024 | The c.3332C>T (p.S1111L) alteration is located in exon 8 (coding exon 7) of the LATS1 gene. This alteration results from a C to T substitution at nucleotide position 3332, causing the serine (S) at amino acid position 1111 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MutPred
Loss of phosphorylation at S1111 (P = 0.0324);Loss of phosphorylation at S1111 (P = 0.0324);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at